Breathe Well Live Well
|
Partnership to Provide Evidence-Based Asthma Management and Sustainable …
Newswise (press release) Newswise — WASHINGTON and NEW YORK (October 5, 2011)—The George Washington University School of Public Health and Health Services, the RCHN Community Health Foundation (RCHN CHF), and Rho have partnered with The Merck Childhood Asthma Network, … |
View full post on asthma – Google News
 The Star-Ledger – NJ.com |
NJ's Merck forges partnership to develop new medicines for asthma and other …
The Star-Ledger – NJ.com Lycera is working on drug candidates that target two pathways, so called Th17 cells and RORyt, that play a critical role in immune-mediated diseases, including psoriasis, asthma and inflammatory bowel disease. Merck, which is based in Whitehouse … Merck and Lycera to Develop Oral Autoimmune Disease Drugs Targeting Th17 Cells |
View full post on asthma – Google News